Single nightly administration of ketoprofen (Orudis) and indomethacin suppositories in the management of osteoarthritis: a double-blind trial. 1977

G Fava, and L Galli, and C Pollini, and C Liverta, and A Vicari, and A E Pontiroli

In a double-blind trial carried out on 60 patients with osteoarthritis at various localizations, ketoprofen (Orudis), administered as a single nightly 100 mg suppository for ten days, was significantly more active and better tolerated than indomethacin, administered in the same way. Patient's and doctor's assessment was also in favour of Orudis. Laboratory examinations were not affected by either drug.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D010666 Phenylpropionates Derivatives of 3-phenylpropionic acid, including its salts and esters.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal

Related Publications

G Fava, and L Galli, and C Pollini, and C Liverta, and A Vicari, and A E Pontiroli
January 1976, The Journal of international medical research,
G Fava, and L Galli, and C Pollini, and C Liverta, and A Vicari, and A E Pontiroli
January 1979, Scandinavian journal of rheumatology. Supplement,
G Fava, and L Galli, and C Pollini, and C Liverta, and A Vicari, and A E Pontiroli
January 1976, Rheumatology and rehabilitation,
G Fava, and L Galli, and C Pollini, and C Liverta, and A Vicari, and A E Pontiroli
May 1979, Rheumatology and rehabilitation,
G Fava, and L Galli, and C Pollini, and C Liverta, and A Vicari, and A E Pontiroli
July 1974, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
G Fava, and L Galli, and C Pollini, and C Liverta, and A Vicari, and A E Pontiroli
April 1981, The New Zealand medical journal,
G Fava, and L Galli, and C Pollini, and C Liverta, and A Vicari, and A E Pontiroli
January 1989, Scandinavian journal of rheumatology. Supplement,
G Fava, and L Galli, and C Pollini, and C Liverta, and A Vicari, and A E Pontiroli
January 1981, The British journal of clinical practice,
G Fava, and L Galli, and C Pollini, and C Liverta, and A Vicari, and A E Pontiroli
April 1975, European journal of clinical pharmacology,
G Fava, and L Galli, and C Pollini, and C Liverta, and A Vicari, and A E Pontiroli
June 1969, Indian pediatrics,
Copied contents to your clipboard!